Zobrazeno 1 - 7
of 7
pro vyhledávání: '"J G M, Scharenberg"'
Processing cord blood from premature infants into autologous red-blood-cell products for transfusion
Autor:
J. G. M. Scharenberg, C. M. Khodabux, F. El Barjiji, Anneke Brand, J. M. van Beckhoven, M. C. Slot
Publikováno v:
Vox Sanguinis. 100:367-373
Background and Objectives The use of umbilical cord blood (UCB) for transfusion purposes has gained interest the past years. UCB transfusion could serve premature infants, who often need transfusions early in life. Material and Methods We investigate
Autor:
S. G. M. Meuwissen, R.J. Scheper, B. M. E. Von Blomberg, J. G. M. Scharenberg, M. Oudkerk Pool, Amado Salvador Peña, G. Bouma, Jeroen J. Kolkman
Publikováno v:
Scandinavian Journal of Gastroenterology. 30:1095-1100
Tumor necrosis factor alpha (TNF alpha) and beta (TNF beta) appear to play an important role in the regulation of the inflammatory response. The aim of the present study was to investigate the intrinsic capacity of peripheral blood mononuclear cells
Autor:
R.J. Scheper, G. J. Roest, P. A. Palmer, B.M.E. von Blomberg, Anita G.M. Stam, Chris J.L.M. Meijer, C.R. Franks, J. G. M. Scharenberg
Publikováno v:
Cancer Immunology, Immunotherapy. 39:34-40
The toxicity of high-dose recombinant interleukin-2 (rIL-2) treatment limits its use in tumour therapies. This paper describes in vitro studies of whether a single, peak rIL-2 dose, followed by low maintenance doses, could enhance the cytotoxic poten
Processing cord blood from premature infants into autologous red-blood-cell products for transfusion
Publikováno v:
Vox sanguinis. 100(4)
The use of umbilical cord blood (UCB) for transfusion purposes has gained interest the past years. UCB transfusion could serve premature infants, who often need transfusions early in life.We investigated the suitability of different storage media. UC
Autor:
J. G. M. Scharenberg, Anita G.M. Stam, B.M.E. von Blomberg, R.J. Scheper, Chris J.L.M. Meijer, G. J. Roest, C.R. Franks, P.A. Palmer
Publikováno v:
European journal of cancer (Oxford, England : 1990). (12)
Serum samples from 217 cancer patients participating in phase I/II clinical trials were analysed for the development of anti-interleukin-2 (IL-2) antibodies. Patients received recombinant human IL-2 (rIL-2) by continuous intravenous infusion (c.i.v.;
Autor:
C.R. Franks, John Wagstaff, W.O. Schreuder, P.A. Palmer, R.J. Scheper, C.H. Polman, J.G. Wolbers, J. G. M. Scharenberg, Jan J. Heimans, J.W. Baars
Publikováno v:
Surgical neurology. 35(3)
A 42-year-old man developed leptomeningeal carcinomatosis 6 years after treatment of a malignant melanoma. He was treated with two courses of recombinant interleukin-2, administered as a continuous intraventricular infusion (6 × 10E5 U/24 h) during
Autor:
J. G. M. Scharenberg, Bruce G. Jenks, Gerard J. M. Martens, A. P. van Overbeeke, J. H. H. N. van Daal
Publikováno v:
Journal of Endocrinology. 98:19-34
This report concerns biosynthetic studies conducted with neurointermediate lobes of the mouse pituitary gland. High performance liquid chromatography was used to resolve newly synthesized peptides after in-vitro incubation of lobes with radioactive a